Bonefos
Generic drug strategic relaunch: Built team, executed one-year campaign for Bayer UK. Achieved fivefold profit increase with innovative sales and marketing, surpassing expectations for significant company success.
Herceptin subcutaneous
Novel Herceptin formulation for breast cancer. Led cross-functional team in national sales, marketing, medical, and reimbursement strategy. Formed a national KOL advisory board and orchestrated successful launch meetings. Achieved Roche’s highest sales uptake for a product launch.
AvandaMet
AvandaMet: Type 2 diabetes combo drug for primary care. Led strategy integrating marketing, PCT reimbursement, and secondary care endorsement. Launched GP and pharmacist training, boosting adoption. Achieved 75% market penetration in 12 months, marking a top GSK primary care launch.
Vismodegib (Erivedge)
Vemurafenib (Zelboraf)
Seretide
Mabthera
Apremilast (Otezla)
